Skip Navigation


JAC Advance Access originally published online on December 1, 2004
Journal of Antimicrobial Chemotherapy 2005 55(1):1-5; doi:10.1093/jac/dkh506
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/1/1    most recent
dkh506v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Masterton, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masterton, R. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

JAC vol.55 no.1 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved

Leading article

Antibiotic cycling: more than it might seem?

Robert G. Masterton*

Ayrshire and Arran Acute Hospitals Trust, Crosshouse Hospital, Kilmarnock, Ayrshire KA2 0BE, UK

* Tel: +44-1563-577004; Email: robert.masterton{at}aaaht.scot.nhs.uk

In the present battle against the rising tide of resistance, several interventions have been proposed to help control the situation. One of these is a process of planned antibiotic restriction, introduced through cycling drug selection based on local surveillance. Although such antibiotic cycling has been the subject of much discussion for 20 years, there are relatively few data available to assess its worth. A recent systematic review found only four studies worthy of inclusion and concluded that antibiotic cycling could not, at present, be promoted as a methodology to control resistance. This paper considers the complete literature and through demonstrating consistent benefits across the breadth and depth of the findings, suggests that whereas further work is required, nevertheless antibiotic cycling—as part of a suite of control measures—is a valid option.

Keywords: resistance , nosocomial infections , prescribing practice


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
A. Sandiumenge, E. Diaz, A. Rodriguez, L. Vidaur, L. Canadell, M. Olona, M. Rue, and J. Rello
Impact of diversity of antibiotic use on the development of antimicrobial resistance
J. Antimicrob. Chemother., June 1, 2006; 57(6): 1197 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
C. MacDougall and R. E. Polk
Antimicrobial Stewardship Programs in Health Care Systems
Clin. Microbiol. Rev., October 1, 2005; 18(4): 638 - 656.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. T. Magee
The resistance ratchet: theoretical implications of cyclic selection pressure
J. Antimicrob. Chemother., August 1, 2005; 56(2): 427 - 430.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.